Federal Circuit Affirms Obviousness of Novartis S Patent for Multiple Sclerosis Drug
Written by Daniel P. Hughes and Karen M. Cassidy The Federal Circuit affirmed the PTAB’s final written decision holding that claims directed to Novartis’s multiple sclerosis drug Gilenya were obvious in Novartis AG v. Torrent Pharmaceuticals.…
April 17, 2017PTAB1 min read